Empowering mental health professionals with peer-reviewed psychiatric research and insights
Page 3
More JCP Articles
Clinical and Practical Psychopharmacology
Cannabis Use in Pregnancy and ASD or ADHD in Offspring
December 23, 2024
Although the number of cannabis-exposed pregnancies (with ASD and ADHD as the outcomes) in world literature is small, cannabis use during pregnancy is a clear marker for adverse neurodevelopmental…
Academic Highlights
Difficult to Treat Depression: Focus on Approach, Algorithms, and Access
November 25, 2024
The Southwest Forum on Difficult to Treat Depression brought together 11 experts to discuss aspects of managing difficult-to-treat depression. This article presents highlights from the forum, covering such topics…
Clinical and Practical Psychopharmacology
Understanding Meta-Analysis Using Gestational Exposure to Cannabis and Birth Defects
November 20, 2024
Dr Andrade discusses strengths and limitations of two recent meta-analyses on birth defects associated with cannabis exposure, with a view to providing readers with a deeper understanding of how…
Insights
What are the Efficacy and Safety of Muscarinic Receptor Modulators in Patients With Schizophrenia?
November 19, 2024
In this video, Dr. Correll examines the therapeutic potential of the muscarinic receptor system in schizophrenia treatment. He discusses how targeting muscarinic receptors may address cognitive and functional impairments,…
Insights
What is the Place of Muscarinic Receptor Modulators in the Clinical Care of Patients With Schizophrenia?
November 19, 2024
This video features Dr. Christoph Correll discussing the clinical application of muscarinic receptor modulators in schizophrenia treatment. He explores their unique mechanism of action, compares them to traditional antipsychotics,…
